收费全文 | 43754篇 |
免费 | 2752篇 |
国内免费 | 166篇 |
耳鼻咽喉 | 549篇 |
儿科学 | 1212篇 |
妇产科学 | 852篇 |
基础医学 | 6254篇 |
口腔科学 | 4046篇 |
临床医学 | 3421篇 |
内科学 | 8981篇 |
皮肤病学 | 925篇 |
神经病学 | 3207篇 |
特种医学 | 917篇 |
外国民族医学 | 4篇 |
外科学 | 4723篇 |
综合类 | 486篇 |
一般理论 | 11篇 |
预防医学 | 5367篇 |
眼科学 | 577篇 |
药学 | 3072篇 |
中国医学 | 403篇 |
肿瘤学 | 1665篇 |
2023年 | 379篇 |
2022年 | 957篇 |
2021年 | 1553篇 |
2020年 | 1069篇 |
2019年 | 1323篇 |
2018年 | 1583篇 |
2017年 | 1163篇 |
2016年 | 1234篇 |
2015年 | 1449篇 |
2014年 | 1909篇 |
2013年 | 2269篇 |
2012年 | 3436篇 |
2011年 | 3754篇 |
2010年 | 1984篇 |
2009年 | 1489篇 |
2008年 | 2554篇 |
2007年 | 2524篇 |
2006年 | 2200篇 |
2005年 | 1886篇 |
2004年 | 1657篇 |
2003年 | 1507篇 |
2002年 | 1336篇 |
2001年 | 849篇 |
2000年 | 911篇 |
1999年 | 736篇 |
1998年 | 270篇 |
1997年 | 186篇 |
1996年 | 171篇 |
1995年 | 148篇 |
1994年 | 141篇 |
1993年 | 112篇 |
1992年 | 339篇 |
1991年 | 305篇 |
1990年 | 303篇 |
1989年 | 285篇 |
1988年 | 261篇 |
1987年 | 199篇 |
1986年 | 202篇 |
1985年 | 200篇 |
1984年 | 153篇 |
1983年 | 118篇 |
1979年 | 122篇 |
1978年 | 107篇 |
1975年 | 82篇 |
1974年 | 84篇 |
1973年 | 98篇 |
1970年 | 98篇 |
1969年 | 99篇 |
1968年 | 87篇 |
1967年 | 91篇 |
Objective
Hypertonic saline (HTS) has potent immune and vascular effects. We assessed recipient pretreatment with HTS on allograft function in a porcine model of heart transplantation and hypothesized that HTS infusion would limit endothelial and left ventricular (LV) dysfunction following transplantation.Methods
Heart transplants were performed after 6 hours of cold ischemic storage. Recipient pigs were randomized to treatment with or without HTS (7.5% NaCl) before cardiopulmonary bypass (CPB). Using a myograft apparatus, coronary artery endothelial-dependent (Edep) and -independent (Eind) relaxation was assessed. LV performance was determined using pressure-volume loop analysis. Pulmonary interleukin (IL)-2, IL-6, and tumor necrosis factor (TNF)-α expression was measured.Results
Weaning from CPB and LV performance after transplantation were improved in HTS-treated animals. Successful weaning from CPB was greater in the HTS-treated hearts (8 of 8 vs 2 of 8; P < .05). Mean LV functional recovery was improved in the HTS-treated animals, as assessed by preload recruitable stroke work (65 ± 10% vs 27 ± 10%; P < .001) and end-systolic elastance (55 ± 7% vs 37 ± 4%; P < .001). Treatment with HTS resulted in improved Edep (mean maximum elastance [Emax], 56 ± 5% vs 37 ± 7%; P < .001) and Eind (mean Emax%, 77 ± 6% vs 52 ± 4%; P < .001) vasorelaxation compared with control. Pulmonary expression of IL-2, IL-6, and TNF-α increased following transplantation, whereas HTS therapy attenuated IL production (P < .001). Transplantation increased plasma TNF-α levels and LV TNF-α expression, whereas HTS prevented this up-regulation (P < .001).Conclusions
Recipient HTS pretreatment preserves allograft vasomotor and LV function, and HTS therapy limits CPB-induced injury. HTS may be a novel recipient intervention to prevent graft dysfunction. 相似文献Background Drug-related problems are mostly preventable or predictable circumstances that may impact on health outcomes. Clinical pharmacy activities such as medication therapy management can identify and solve these problems, with potential to improve medication safety and effectiveness. Objective To evaluate ability of medication therapy management service to detect drug-related problems and prevent adverse drug events. This study also aimed to assess the risk factors for drugrelated problem occurrence. Setting Medical intensive care unit of a public tertiary hospital in Brazil. Methods Patients were evaluated by a clinical pharmacist, who provided medication therapy management service. Detected drug-related problems were categorized according to the Pharmaceutical Care Network Europe methodology and analyzed in multinomial regression to identify risk factors. Main outcome measure Potential risk factors for drug-related problem occurrence. Results The proposed medication therapy management service allowed detection of 170 drug-related problems that had potential to reach patients causing harm and other 50 unavoidable adverse events. Drug-related problems identified were more often associated with antibacterial use, caused by improper combinations or inadequate drug dosage. These problems required interventions that were accepted by the multidisciplinary team, resulting in more than 85% adherence and total problem solving. Main risk factors identified were previous diagnosis of kidney injury (OR?=?8.38), use of midazolam (OR?=?7.96), furosemide (OR?=?5.87) and vancomycin (OR?=?4.82). Conclusion Medication therapy management proved to be an effective method not only for drug-related problem detection, but also for adverse drug event prevention, contributing to improve patient safety.
相似文献